The group's principle activities include developing and commercializing biopharmaceutical products for autoimmune disease, inflammation, and pain. The group’s marketing products include Norvasc, Lipitor, Viagra, Glucotrol XL, Rituxan, Gonal-f(R), Duragesic, Zestril, and Nolvadex. The group operates from United States.
